Skip to main content

Table 1 Patients’ clinical and demographic data (n = 526)

From: Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China

Characteristics

No. of patients

Gender

 

 Male

226 (43%)

 Female

300 (57%)

Age at hospitalization (years)

 

Median (range)

59 (27–85)

 < 50

117 (22%)

 ≥ 50

409 (78%)

PCI

 

Median (range)

31 (12–39)

 < 30

195 (37%)

 ≥ 30

331 (63%)

CCR

 

 2

229 (44%)

 3

297 (56%)

Operation time (min)

 

Median (range)

490 (99–872)

 < 480

240 (46%)

 ≥ 480

286 (54%)

Blood loss (ml)

 

Median (range)

1500 (0-11000)

 < 1000

89 (17%)

 ≥ 1000

437 (83%)

HIPEC

 

 Yes

407 (77%)

 No

119 (23%)

HIPEC drug regimen

 

 MMC

174 (33%)

 DDP

220 (42%)

 MMC + DDP

13 (2%)

PSC

 

 Yes

158 (30%)

 No

368 (70%)

Previous surgery

 

 Yes

289 (55%)

 No

237 (45%)

Pathological grade

 

 LG-MCP

367 (70%)

 HG-MCP

106 (20%)

 HGMC-S

53 (10%)

  1. PCI peritoneal cancer index, CCR completeness of cytoreduction, HIPEC hyperthermic intraperitoneal chemotherapy, MMC mitomycin, DDP cisplantin, PSC previous systemic chemotherapy, LG-MCP low-grade mucinous carcinoma peritonei, HG-MCP high-grade mucinous carcinoma peritonei, HGMC-S high-grade mucinous carcinoma peritonei with signet ring cells